Skip to main content
Fig. 2 | BMC Pregnancy and Childbirth

Fig. 2

From: Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women

Fig. 2

Cost-effectiveness plane. Scatter plot on the cost-effectiveness plane showing the difference in costs (pertaining to RHD negative status) and performance from GENIFERH1 data using 1000 bootstrap replicates. The genotyping arm cost of resources per patient was on average €139 more expensive than the control arm. The genotyping arm was more performant with an increase in effectiveness of 24%

Back to article page